81 FR 15564 - Manufacturer of Controlled Substances Registration: Halo Pharmaceutical, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 81, Issue 56 (March 23, 2016)
Drug Enforcement Administration
Federal Register Volume 81, Issue 56 (March 23, 2016)
| Page Range | 15564-15564 | |
| FR Document | 2016-06533 |
[Federal Register Volume 81, Number 56 (Wednesday, March 23, 2016)] [Notices] [Page 15564] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-06533] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Manufacturer of Controlled Substances Registration: Halo Pharmaceutical, Inc. ACTION: Notice of registration. ----------------------------------------------------------------------- SUMMARY: Halo Pharmaceutical, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Halo Pharmaceutical, Inc. registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated October 13, 2015, and published in the Federal Register on October 21, 2015, 80 FR 63838, Halo Pharmaceutical, Inc., 30 North Jefferson Road, Whippany, New Jersey 07981 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Halo Pharmaceutical, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Schedule ------------------------------------------------------------------------ Dihydromorphine (9145)..................... I Hydromorphone (9150)....................... II ------------------------------------------------------------------------ The company plans to manufacture Hydromorphone HCl for sale to other manufacturers and to manufacture other controlled substances for distribution to its customers. Dihydromorphine is an intermediate in the manufacture of Hydromorphone and is not for commercial distribution. Dated: March 14, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016-06533 Filed 3-22-16; 8:45 am] BILLING CODE 4410-09-P
![15564 Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices
Controlled substance Schedule
Pentobarbital (2270) .................................................................................................................................................................................... II
Secobarbital (2315) ..................................................................................................................................................................................... II
Glutethimide (2550) ..................................................................................................................................................................................... II
Nabilone (7379) ........................................................................................................................................................................................... II
1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. II
Phencyclidine (7471) ................................................................................................................................................................................... II
1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................ II
Alphaprodine (9010) .................................................................................................................................................................................... II
Cocaine (9041) ............................................................................................................................................................................................ II
Codeine (9050) ............................................................................................................................................................................................ II
Dihydrocodeine (9120) ................................................................................................................................................................................ II
Oxycodone (9143) ....................................................................................................................................................................................... II
Hydromorphone (9150) ............................................................................................................................................................................... II
Diphenoxylate (9170) .................................................................................................................................................................................. II
Ecgonine (9180) .......................................................................................................................................................................................... II
Ethylmorphine (9190) .................................................................................................................................................................................. II
Hydrocodone (9193) .................................................................................................................................................................................... II
Levomethorphan (9210) .............................................................................................................................................................................. II
Levorphanol (9220) ..................................................................................................................................................................................... II
Isomethadone (9226) .................................................................................................................................................................................. II
Meperidine (9230) ....................................................................................................................................................................................... II
Meperidine intermediate-A (9232) ............................................................................................................................................................... II
Meperidine intermediate-B (9233) ............................................................................................................................................................... II
Meperidine intermediate-C (9234) ............................................................................................................................................................... II
Metazocine (9240) ....................................................................................................................................................................................... II
Methadone (9250) ....................................................................................................................................................................................... II
Methadone intermediate (9254) .................................................................................................................................................................. II
Dextropropoxyphene, bulk (non-dosage forms) (9273) .............................................................................................................................. II
Morphine (9300) .......................................................................................................................................................................................... II
Thebaine (9333) .......................................................................................................................................................................................... II
Levo-alphacetylmethadol (9648) ................................................................................................................................................................. II
Oxymorphone (9652) ................................................................................................................................................................................... II
Noroxymorphone (9668) .............................................................................................................................................................................. II
Racemethorphan (9732) .............................................................................................................................................................................. II
Alfentanil (9737) .......................................................................................................................................................................................... II
Remifentanil (9739) ..................................................................................................................................................................................... II
Sufentanil (9740) ......................................................................................................................................................................................... II
Carfentanil (9743) ........................................................................................................................................................................................ II
Tapentadol (9780) ....................................................................................................................................................................................... II
Fentanyl (9801) ........................................................................................................................................................................................... II
The company plans to manufacture grants Halo Pharmaceutical, Inc. local laws, and reviewing the company’s
small quantities of the listed controlled registration as a manufacturer of those background and history.
substances to make reference standards controlled substances. Therefore, pursuant to 21 U.S.C.
which will be distributed to their SUPPLEMENTARY INFORMATION: By notice 823(a), and in accordance with 21 CFR
customers. dated October 13, 2015, and published 1301.33, the above-named company is
Dated: March 14, 2016. in the Federal Register on October 21, granted registration as a bulk
Louis J. Milione, 2015, 80 FR 63838, Halo manufacturer of the following basic
Deputy Assistant Administrator.
Pharmaceutical, Inc., 30 North Jefferson classes of controlled substances:
Road, Whippany, New Jersey 07981
[FR Doc. 2016–06535 Filed 3–22–16; 8:45 am]
applied to be registered as a Controlled substance Schedule
BILLING CODE 4410–09–P
manufacturer of certain basic classes of
controlled substances. No comments or Dihydromorphine (9145) ............... I
objections were submitted for this Hydromorphone (9150) ................ II
DEPARTMENT OF JUSTICE
notice.
Drug Enforcement Administration The DEA has considered the factors in The company plans to manufacture
21 U.S.C. 823(a) and determined that Hydromorphone HCl for sale to other
[Docket No. DEA–392] the registration of Halo Pharmaceutical, manufacturers and to manufacture other
Inc. to manufacture the basic classes of controlled substances for distribution to
Manufacturer of Controlled controlled substances is consistent with
Substances Registration: Halo its customers. Dihydromorphine is an
the public interest and with United intermediate in the manufacture of
Pharmaceutical, Inc. States obligations under international
jstallworth on DSK7TPTVN1PROD with NOTICES
Hydromorphone and is not for
ACTION: Notice of registration. treaties, conventions, or protocols in commercial distribution.
effect on May 1, 1971. The DEA
Dated: March 14, 2016.
SUMMARY: Halo Pharmaceutical, Inc. investigated the company’s maintenance
applied to be registered as a of effective controls against diversion by Louis J. Milione,
manufacturer of certain basic classes of inspecting and testing the company’s Deputy Assistant Administrator.
controlled substances. The Drug physical security systems, verifying the [FR Doc. 2016–06533 Filed 3–22–16; 8:45 am]
Enforcement Administration (DEA) company’s compliance with state and BILLING CODE 4410–09–P
VerDate Sep<11>2014 15:26 Mar 22, 2016 Jkt 238001 PO 00000 Frm 00067 Fmt 4703 Sfmt 9990 E:\FR\FM\23MRN1.SGM 23MRN1](https://thefederalregister.org/doc/81_FR_15620/page/1.svg)
Document Created: 2016-03-23 00:04:01
Document Modified: 2016-03-23 00:04:01
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of registration. | |
| FR Citation | 81 FR 15564 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR